The BioAg Alliance: First full year trials show yield increases in corn and soy
Jan. 8, 2015
“For microbial performance, which typically stands out under more stressed conditions, this type of benefit in favorable growing conditions is very promising,” says Novozymes’ Vice President Colin Bletsky. “These technologies have significant potential to support continued advancements in modern agriculture and help meet growing global demand for food. They help farmers produce more crops with fewer inputs.”
With the formation of The BioAg Alliance just under a year ago, the progress has been impressive. The partners are leveraging Monsanto’s global network to increase the reach of existing commercial products – from Optimize® inoculant for soybeans in the United States to Torque® inoculant for corn in Ukraine – and new product candidates are currently in development. Novozymes and Monsanto conducted over 170,000 trials across hundreds of microbial strains in 2014 and plan to expand trials in 2015. The partners also continue to collaborate with and evaluate third party microbial technologies in addition to those under development by the companies.
“Monsanto remains focused on delivering innovations for agriculture that help increase the amount of crops that make it to harvest and further support the efficient use of natural resources,” says Tom Adams, Vice President of Global Biotechnology at Monsanto. “We are proud to collaborate with Novozymes to bring scale to microbial testing that’s never been seen before. We believe the collective microbial discovery, field testing capability and fermentation production expertise will deliver new options for farmers.”
More from AgroNews
Subscribe to daily email alerts of AgroNews.